share_log

宣泰医药(688247.SH):12月公司未实施股份回购

Xuantai Pharmaceutical (688247.SH): The company did not implement a share buyback in December.

Gelonghui Finance ·  Jan 1 15:40

On January 1, Gelonghui announced that Xuantai Pharmaceutical (688247.SH) reported that by December 2024, the company had not implemented any share buybacks. As of December 31, 2024, the company had repurchased a total of 4.3361 million shares through the centralized bidding trading system of the Shanghai Exchange, accounting for 0.96% of the company's total equity. The highest purchase price was 8.98 yuan/share, the lowest was 7.40 yuan/share, and the total amount paid was 36.126 million yuan (excluding stamp duty, transaction commissions, and other transaction fees).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment